Concerta xl 18 mg - Common Side Effects of Concerta (Methylphenidate Extended-Release Tablets) Drug Center - RxList
It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. Concerta to use Concerta Read the Medication Guide provided by your pharmacist before you start taking methylphenidate and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning.
Taking this medication late in the day may cause trouble sleeping insomnia. Do not crush or chew this medication. Doing so can release all of the drug at once, increasing the risk of side effects. Remember that some foods and medicines contain alcohol. Tell your doctor or pharmacist if any of the above apply to you before starting treatment. This is because methylphenidate can make these problems worse.
Your doctor will want to monitor how the medicine affects you. During treatment, concerta xl 18 mg, boys and adolescents may unexpectedly experience prolonged erections.
This may be painful and can occur at any time. It is important to contact your doctor straight away if your erection lasts for longer than 2 hours, concerta xl 18 mg, particularly if this is painful. It is not known if methylphenidate will affect an unborn baby. Tell your doctor or pharmacist before using methylphenidate if you are: Your doctor will decide whether you should take methylphenidate.
It is possible that methylphenidate is passed into human breast milk. If paradoxical aggravation of symptoms or other serious adverse events occur, the dosage should be reduced or discontinued.
Adults In adolescents whose symptoms persist into adulthood and who have shown clear benefit from treatment, it may be appropriate to continue treatment into adulthood, concerta xl 18 mg.
However, start of treatment with Concerta XL in adults is not appropriate see sections 4. Elderly Methylphenidate should not be used in the elderly. Safety and efficacy has not been established in this age group. Children under 6 years of age Methylphenidate should not be used in children under the age of 6 years. Safety and efficacy in this age group has not been established.
Method of administration Concerta XL must be swallowed whole with the aid of liquids, and must not be chewed, divided, or crushed see section 4. Concerta XL may concerta administered with or without food see section 5. Concerta XL is taken once daily in the morning. Long-term use more than 12 months in children and adolescents The safety and efficacy of long-term use of methylphenidate has not been systematically evaluated in controlled trials. Patients on long-term therapy i. Psychiatric disorders to monitor for are described below, concerta xl 18 mg, and include but are not limited to motor or vocal tics, aggressive or hostile behaviour, agitation, anxiety, depression, psychosis, mania, delusions, irritability, lack of spontaneity, withdrawal and excessive perseveration, concerta xl 18 mg.
It is recommended that methylphenidate is de-challenged at least once yearly to assess the child's condition preferably during times of school holidays. Use in adults Safety and phenytoin tamiflu interaction have not been established for the initiation of treatment in adults or the routine continuation of treatment beyond 18 years of age, concerta xl 18 mg.
If treatment withdrawal has not been successful when an adolescent has reached 18 years of age continued treatment into adulthood may be necessary.
Oxycodone with acetaminophen classification need for further treatment of these adults should be reviewed regularly and undertaken annually.
Use in the elderly Methylphenidate should not be used in the elderly. Use in concerta under 6 years of age Methylphenidate should not be used in children under the age of 6 years. Cardiovascular status Patients who are being considered for treatment with stimulant medications should have a careful history including assessment for a family history of sudden cardiac or unexplained death or malignant arrhythmia and physical exam to assess for the presence of cardiac disease, and should receive further specialist cardiac evaluation if initial findings suggest such history or disease.
What Is In Concerta XL
Patients who develop symptoms such as palpitations, exertional chest pain, unexplained syncope, dyspnoea or other symptoms suggestive of cardiac disease during methylphenidate treatment should undergo concerta prompt specialist cardiac evaluation. Analyses of data from clinical trials of methylphenidate in children and adolescents with ADHD showed that patients using methylphenidate may commonly experience changes in diastolic and systolic blood pressure of over 10 mmHg relative to controls, concerta xl 18 mg.
The short- and long-term clinical consequences of these cardiovascular effects in children and adolescents are not known. Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate. Cardiovascular status should be carefully monitored. Blood pressure and pulse should be recorded on a centile chart at each adjustment of dose and then at least every 6 months.
The use of methylphenidate is contraindicated in certain pre-existing cardiovascular disorders unless specialist paediatric cardiac advice has been obtained see section 4. Sudden death and pre-existing structural cardiac abnormalities or other serious cardiac disorders Sudden death has been reported in association with the use of stimulants of the central nervous system at usual doses in children, some of whom had structural cardiac abnormalities or other serious heart problems, concerta xl 18 mg.
Although some serious heart problems alone may carry an increased risk of sudden death, stimulant products are not recommended in children or adolescents with known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant medicine.
Misuse and cardiovascular events Misuse of stimulants of the central nervous system may be associated with sudden death and other serious cardiovascular adverse events.
Cerebrovascular disorders See section 4. Patients with additional risk factors such as a history of cardiovascular disease, concomitant medications that elevate blood pressure should be assessed at every visit for neurological signs and symptoms concerta initiating treatment with methylphenidate. Cerebral vasculitis appears to be a very rare idiosyncratic reaction to methylphenidate exposure.
There is little evidence to suggest that patients at higher risk can be identified and the initial onset of symptoms may be endep withdrawal treatment first indication of an underlying clinical problem.
Early diagnosis, based on a high index of suspicion, may allow the prompt withdrawal of methylphenidate and early treatment. The diagnosis should therefore be considered in any patient who develops new neurological symptoms that are consistent with cerebral ischemia during methylphenidate therapy.
These symptoms could include severe headache, concerta xl 18 mg, numbness, weakness, paralysis, and impairment of coordination, vision, speech, language or memory. Treatment with methylphenidate is not contraindicated in patients with hemiplegic cerebral palsy.
Psychiatric disorders Co-morbidity of psychiatric disorders in ADHD is common and should be taken into account when prescribing stimulant products. In the case of emergent psychiatric symptoms or exacerbation of pre-existing psychiatric disorders, methylphenidate should not be given unless the benefits outweigh the risks to the patient.
Development or worsening of psychiatric disorders should be monitored at every adjustment of dose, then at least every 6 months, and at every visit; discontinuation of treatment may be appropriate. Exacerbation of pre-existing psychotic or manic symptoms In psychotic patients, administration of methylphenidate may exacerbate symptoms of behavioural disturbance and thought disorder. If manic or psychotic symptoms occur, consideration should be given to a possible causal role for methylphenidate, concerta discontinuation of treatment may be appropriate.
Aggressive or hostile behaviour The emergence or worsening of aggression or hostility can be caused by treatment with stimulants, concerta xl 18 mg.
Aggression has been reported in patients treated with methylphenidate see section 4. Patients treated concerta methylphenidate should be closely monitored for the emergence or worsening of aggressive behaviour or hostility at treatment initiation, at every dose adjustment and then at concerta every 6 months and every visit.
Physicians should evaluate the need for adjustment of the treatment regimen in patients experiencing behaviour changes bearing in mind that upwards or downwards titration may be appropriate. Treatment interruption can be considered.
CONCERTA XL 18 MG PROLONGED RELEASE TABLETS
Suicidal tendency Patients concerta emergent suicidal ideation or behaviour during treatment for ADHD should be evaluated immediately by their physician. Consideration should be given to the exacerbation of an underlying psychiatric condition and to a possible causal role of methylphenidate treatment. Treatment of meloxicam overdose treatment underlying psychiatric condition may be necessary and consideration should be given to a possible discontinuation of methylphenidate, concerta xl 18 mg.
Tics Methylphenidate is associated with the onset or exacerbation of motor and verbal tics, concerta xl 18 mg. Worsening of Tourette's syndrome has also been reported.
Tags: can i take fluconazole with trimethoprim cozaar for sale concerta xl 18 mg